MannKind Corp
MNKD
#4917
Rank
A$2.62 B
Marketcap
A$8.55
Share price
-0.53%
Change (1 day)
-18.05%
Change (1 year)

MannKind Corp (MNKD) - Cash on Hand

Cash on Hand as of September 2025 : A$0.39 Billion

According to MannKind Corp's latest financial reports the company has A$0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MannKind Corp - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.31 B-26.78%
2023-12-31A$0.43 B72.53%
2022-12-31A$0.25 B-10.83%
2021-12-31A$0.28 B223.09%
2020-12-31A$87.14 M22.31%
2019-12-31A$71.24 M-29.46%
2018-12-31A$0.10 B79.44%
2017-12-31A$56.29 M77.22%
2016-12-31A$31.76 M-60.83%
2015-12-31A$81.09 M-45.08%
2014-12-31A$0.14 B86.05%
2013-12-31A$79.36 M33.37%
2012-12-31A$59.5 M2175.86%
2011-12-31A$2.61 M-96.23%
2010-12-31A$69.33 M91.69%
2009-12-31A$36.17 M-45.11%
2008-12-31A$65.89 M-84.36%
2007-12-31A$0.42 B-23.92%
2006-12-31A$0.55 B178.19%
2005-12-31A$0.19 B70.13%
2004-12-31A$0.11 B55.44%
2003-12-31A$75.26 M36.56%
2002-12-31A$55.11 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Halozyme Therapeutics
HALO
A$1.05 B 169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$7.71 B 1,870.31%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
A$27.42 B 6,904.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$14.92 B 3,712.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.40 B 3.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$22.55 B 5,662.30%๐Ÿ‡บ๐Ÿ‡ธ USA